Search

Your search keyword '"Cho, Myeong-Chan"' showing total 1,379 results

Search Constraints

Start Over You searched for: Author "Cho, Myeong-Chan" Remove constraint Author: "Cho, Myeong-Chan"
1,379 results on '"Cho, Myeong-Chan"'

Search Results

203. Admission Hyperglycemia as a Predictor of Mortality in Acute Heart Failure: Comparison between the Diabetics and Non-Diabetics

206. Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

207. Prognostic Value of QRS Duration among Patients with Cardiogenic Shock Complicating Acute Heart Failure: Data from the Korean Acute Heart Failure (KorAHF) Registry

208. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation

209. Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure Registry

210. Prognostic Value of Pre-Procedural Thrombolysis in Myocardial Infarction Flow in ST-Segment Elevation Myocardial Infarction Patients with Primary Percutaneous Coronary Intervention

211. Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)

212. Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation

213. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction

215. Artificial intelligence algorithm for predicting mortality of patients with acute heart failure

216. Characteristics and outcomes of HFpEF with declining ejection fraction

218. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study

219. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction

220. PROGNOSIS OF PATIENT WITH ACUTE HEART FAILURE ACCORDING TO ONE-YEAR CHANGES IN LEFT VENTRICULAR EJECTION FRACTION

221. β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate

223. Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction

224. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease

226. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

227. Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

228. Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the Korean Acute Heart Failure (KorAHF) Registry

229. Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure

232. Prognostic Implication of Ventricular Conduction Disturbance Pattern in Hospitalized Patients with Acute Heart Failure Syndrome

234. One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction.

236. Characteristics and outcomes of HFpEF with declining ejection fraction.

237. Nutritional risk index as a predictor of mortality in acutely decompensated heart failure

238. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure

240. Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries

241. Effects of Widespread Inotrope Use in Acute Heart Failure Patients

242. A13349 Changes of circadian rhythm using population cosinor model with 24 week antihypertensive treatment of losartan in combination with amlodipine versus dihydrochlorthiazide in hypertension patients

243. Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure

244. Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge

245. Admission Hyperglycemia is a Predictor of Mortality in Acute Heart Failure Patients without diabetes, but not in those with diabetes

247. TCTAP A-006 Utility of GRACE and ACUITY-HORIZONS Risk Scores to Guide Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stenting

248. TCTAP A-093 Effects of Statin Intensity on Clinical Outcomes in Acute Myocardial Infarction Patients

249. Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry

250. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock

Catalog

Books, media, physical & digital resources